David M. Williams, P.T. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2590 Holiday Rd Ste 10, Coralville, IA 52241 Phone: 319-625-3030 Fax: 319-625-3032 |
Molly Ann Camacho, P.T. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2590 Holiday Rd Ste 10, Coralville, IA 52241 Phone: 319-625-3030 Fax: 319-625-3032 |
Caitlin Larsen, DPT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3290 Ridgeway Dr Ste 3, Coralville, IA 52241 Phone: 319-665-2630 |
Ashley Rae Chizek, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3290 Ridgeway Dr, Ste 3, Coralville, IA 52241 Phone: 319-665-2630 Fax: 319-665-2631 |
Jason Lee Abbuhl, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3290 Ridgeway Dr Ste 3, Coralville, IA 52241 Phone: 319-665-2630 Fax: 319-665-2630 |
Jeffrey Scott Swartzendruber, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3290 Ridgeway Dr Ste 3, Coralville, IA 52241 Phone: 319-665-2630 Fax: 319-665-2631 |
Scott M Harms, P.T. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2590 Holiday Rd Ste 10, Coralville, IA 52241 Phone: 319-625-3030 Fax: 319-625-3032 |
Ross Petersen, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3290 Ridgeway Dr Ste 3, Coralville, IA 52241 Phone: 319-665-2630 Fax: 319-665-2631 |
News Archive
Wellcome Trust researchers have identified a key gene involved in the disease Lupus, which affects around 50,000 people in the UK, mostly women.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes.
Giving nitrous oxide as part of general anesthesia for noncardiac surgery doesn't increase the rate of complications and death—and might even decrease the risk of such events, according to a pair of studies in the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
S1 Pharmaceuticals, Inc. (S1) announced today that it has submitted its Investigational New Drug (IND) application to the U.S. Food and Drug Administration for Phase I-b clinical studies of SIP-104 (Lorexys). Lorexys is the Company's lead drug candidate for the treatment of Hypoactive Sexual Desire Disorder (HSDD) and Female Sexual Dysfunction (FSD).
› Verified 1 days ago